Immunotrex has developed Tranosyl,™ a novel intervention utilizing RNA interference technology(RNAi) to inhibit the cell growth of cancerous cells.Tranosyl™ is our method for delivering injurious oligomers for disruptive RNAi through the use of an adenovirus phage capsule containing hairpin RNAi oligomers.The phage arms will be used to provide specificity toward cancer cells.
A classical R&D based company